DOCSLIB.ORG

Proteomics Analysis of Brain AVM Endothelium Post Irradiation in Pursuit of Targets for AVM Molecular Therapy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Proteomics Analysis of Brain AVM Endothelium Post Irradiation in Pursuit of Targets for AVM Molecular Therapy Proteomics analysis of brain AVM endothelium post irradiation in pursuit of targets for AVM molecular therapy Margaret Simonian, BSc, MPhil A thesis presented for the degree of Doctor of Philosophy Australian School of Advanced Medicine Faculty of Medicine and Health Sciences Macquarie University Table of Contents LIST OF FIGURES AND TABLES ......................................................................................... 6 DECLARATION......................................................................................................................11 ACKNOWLEDGMENT ......................................................................................................... 12 Summary .................................................................................................................................. 13 Chapter1. General Introduction ............................................................................................... 14 1.1. Arteriovenous malformations and goals of project ........................................................... 15 1.1.1. Treatment options .......................................................................................................... 16 1.1.2. Development of new treatments for brain AVMs ........................................................... 20 1.2. Vascular endothelium ....................................................................................................... 24 1.2.1. Function of vascular endothelium ................................................................................. 25 1.2.2. Thrombogenesis ............................................................................................................. 25 1.2.3. Thromboresistant properties of vascular endothelium .................................................. 25 - Plasminogen activators……………………………………………………………….26 - Heparin-like molecules………………………………………………………………..26 - Antithrombin III……………………………………………………………………….26 - Annexin V……………………………………………………………………………...26 1.2.4. Endothelial response to irradiation ............................................................................... 27 1.2.5. Selected endothelial vascular molecules and their response to irradiation .................. 28 - PECAM-1……………………………………………………………………………….28 - Cadherin-5…………………………………………………………………………….29 - Integrins……………………………………………………………………………….30 1.3. Membrane proteins ........................................................................................................... 31 1.4.1. Biotinylation ................................................................................................................... 35 1.5. Proteomics .................................................................................................................... 36 1.5.1. Proteomics in medicine .................................................................................................. 38 1.5.2. Quantitative proteomic techniques ................................................................................ 38 - Isobaric Tag for Relative and Absolute Quantitation (iTRAQ) ..................................... 39 - Mass spectrometry expression (MSE) ............................................................................ 40 Chapter 2: In vitro biotinylation protocol optimizations of murine endothelial cell cultures (bEnd3) .................................................................................................................................... 41 2.1 Introduction ........................................................................................................................ 42 2.2. In vitro biotinylation of bEnd.3 cultures - first trial ......................................................... 42 1 2.2.1. Materials and methods .................................................................................................. 42 2.2.1.1. Mouse endothelial cell cultures (bEnd.3) ................................................................... 42 2.2.1.2. Cell density and total protein concentrations ............................................................. 42 2.2.1.3. In vitro biotinylation ................................................................................................... 43 2.2.1.4. Digestion of eluted proteins and LC-MS/MS analysis ................................................ 44 2.2.1.5. Data processing .......................................................................................................... 44 2.3.1. Materials and methods .................................................................................................. 46 2.3.1.1. In vitro biotinylation ................................................................................................... 46 2.3.1.2. One dimensional electrophoreses ............................................................................... 46 2.3.1.3. MALDI-TOF mass spectrometry ................................................................................ 46 2.3.1.4. Data processing .......................................................................................................... 47 2.3.2. Results............................................................................................................................ 47 2.4. In vitro biotinylation of BSA and E.coli - First trial ......................................................... 51 2.4.1.1. Total protein concentration of E.coli.......................................................................... 51 2.4.1.2. In vitro biotinylation of BSA ....................................................................................... 52 2.4.1.3. Capture of biotinylated BSA ....................................................................................... 52 2.4.1.4. Protein digestion, purification and LC-MS/MS analysis ............................................ 52 2.4.2. Results............................................................................................................................ 53 2.5. In vitro biotinylation of BSA and E.coli - Second trial .................................................... 58 2.5.1. Materials and methods .................................................................................................. 58 2.5.1.1. In vitro biotinylation of BSA ....................................................................................... 58 2.5.1.2. Capture of biotinylated BSA ....................................................................................... 58 2.5.1.3. Protein digestion, purification and LC-MS/MS analysis ............................................ 59 2.5.1. Results............................................................................................................................ 59 2.6. In vitro biotinylation of BSA with different biotin concentrations - Third trial ............... 66 2.6.1. Materials and methods .................................................................................................. 66 2.6.1.1. In vitro biotinylation ................................................................................................... 66 2.6.2. Results............................................................................................................................ 67 2.7. In vitro biotinylation of BSA using different biotin concentrations with E.coli .............. 77 2.7.1. Materials and methods .................................................................................................. 77 2.7.1.1. In vitro biotinylation ................................................................................................... 77 2.7.1.2 Results .......................................................................................................................... 78 2.8. In vitro biotinylation of bEnd3 cell cultures - new trials .................................................. 83 2.8.1. Materials and methods .................................................................................................. 83 2.8.1.1. In vitro biotinylation ................................................................................................... 83 2 2.8.1.2. Tryptic digestion of biotinylated proteins and LC-MS/MS analysis ........................... 84 2.8.1.3. Data processing .......................................................................................................... 85 2.8.2. Results ............................................................................................................................ 85 2.9 Western blot analysis of bEnd.3 cells ................................................................................ 88 Chapter3. In vitro biotinylation and iTRAQ-mass spectrometry of bEnd.3 cells ................. 90 3.1 Introduction ........................................................................................................................ 91 3.2 Materials and Methods ....................................................................................................... 91 3.2.1 Mouse endothelial cell cultures (bEnd.3) ....................................................................... 91 3.2.2 Cell density and total protein concentration ................................................................... 91 3.2.3 Irradiation of bEnd.3 cells .............................................................................................. 92 3.2.4 In vitro biotinylation of bEnd.3 cells .............................................................................
Load more

Recommended publications
  • Supervised Group Lasso with Applications to Microarray Data Analysis
    SUPERVISED GROUP LASSO WITH APPLICATIONS TO MICROARRAY DATA ANALYSIS Shuangge Ma1, Xiao Song2, and Jian Huang3 1Department of Epidemiology and Public Health, Yale University 2Department of Health Administration, Biostatistics and Epidemiology, University of Georgia 3Departments of Statistics and Actuarial Science, and Biostatistics, University of Iowa March 2007 The University of Iowa Department of Statistics and Actuarial Science Technical Report No. 375 1 Supervised group Lasso with applications to microarray data analysis Shuangge Ma¤1 Xiao Song 2and Jian Huang 3 1 Department of Epidemiology and Public Health, Yale University, New Haven, CT 06520, USA 2 Department of Health Administration, Biostatistics and Epidemiology, University of Georgia, Athens, GA 30602, USA 3 Department of Statistics and Actuarial Science, University of Iowa, Iowa City, IA 52242, USA Email: Shuangge Ma¤- [email protected]; Xiao Song - [email protected]; Jian Huang - [email protected]; ¤Corresponding author Abstract Background: A tremendous amount of e®orts have been devoted to identifying genes for diagnosis and prognosis of diseases using microarray gene expression data. It has been demonstrated that gene expression data have cluster structure, where the clusters consist of co-regulated genes which tend to have coordinated functions. However, most available statistical methods for gene selection do not take into consideration the cluster structure. Results: We propose a supervised group Lasso approach that takes into account the cluster structure in gene expression data for gene selection and predictive model building. For gene expression data without biological cluster information, we ¯rst divide genes into clusters using the K-means approach and determine the optimal number of clusters using the Gap method.
    [Show full text]
  • Exercise Training-Induced Extracellular Matrix Protein Adaptation in Locomotor Muscles: a Systematic Review
    cells Systematic Review Exercise Training-Induced Extracellular Matrix Protein Adaptation in Locomotor Muscles: A Systematic Review Efpraxia Kritikaki 1, Rhiannon Asterling 1, Lesley Ward 1 , Kay Padget 1, Esther Barreiro 2 and Davina C. M. Simoes 1,* 1 Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle upon Tyne NE1 8ST, UK; effi[email protected] (E.K.); [email protected] (R.A.); [email protected] (L.W.); [email protected] (K.P.) 2 Pulmonology Department, Lung Cancer and Muscle Research Group, Hospital del Mar-IMIM, Parc de Salut Mar, Health and Experimental Sciences Department (CEXS), Universitat Pompeu Fabra (UPF), CIBERES, 08002 Barcelona, Spain; [email protected] * Correspondence: [email protected] Abstract: Exercise training promotes muscle adaptation and remodelling by balancing the processes of anabolism and catabolism; however, the mechanisms by which exercise delays accelerated muscle wasting are not fully understood. Intramuscular extracellular matrix (ECM) proteins are essential to tissue structure and function, as they create a responsive environment for the survival and repair of the muscle fibres. However, their role in muscle adaptation is underappreciated and underinvesti- gated. The PubMed, COCHRANE, Scopus and CIHNAL databases were systematically searched from inception until February 2021. The inclusion criteria were on ECM adaptation after exercise training in healthy adult population. Evidence from 21 studies on 402 participants demonstrates that exercise training induces muscle remodelling, and this is accompanied by ECM adaptation. All types Citation: Kritikaki, E.; Asterling, R.; of exercise interventions promoted a widespread increase in collagens, glycoproteins and proteo- Ward, L.; Padget, K.; Barreiro, E.; C.
    [Show full text]
  • Extracellular Matrix Composition of Connective Tissues: Systematic Review and Meta- Analysis
    1 Extracellular matrix composition of connective tissues: systematic review and meta- analysis Turney McKee, Dentistry Division of Biomedical Sciences, McGill University, Montreal Submitted April, 2018 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Science © Turney McKee 2018 2 Table of Contents Abstract • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 3 Acknowledgements • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 6 Contribution of Authors • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 6 Introduction and Objectives • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 7 Review of the Literature Connective tissue, general introduction • • • • • • • • • • • • • • • • • • • • • • • 9 Extracellular matrix and its components • • • • • • • • • • • • • • • • • • • • • • 9 ECM remodeling and structural requirements • • • • • • • • • • • • • • • • • • 12 Adipose tissue • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 13 Tendon and ligament • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •14 Bone • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 15 Articular Cartilage • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 15 IVD • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 17 Relevance and importance of proteomic composition • • • • • • • • • • • • • • • 18 Methods
    [Show full text]
  • Human PRELP ELISA Kit (ARG82754)
    Product datasheet [email protected] ARG82754 Package: 96 wells Human PRELP ELISA Kit Store at: 4°C Component Cat. No. Component Name Package Temp ARG82754-001 Antibody-coated 8 X 12 strips 4°C. Unused strips microplate should be sealed tightly in the air-tight pouch. ARG82754-002 Standard 2 X 10 ng/vial 4°C ARG82754-003 Standard/Sample 30 ml (Ready to use) 4°C diluent ARG82754-004 Antibody conjugate 1 vial (100 µl) 4°C concentrate (100X) ARG82754-005 Antibody diluent 12 ml (Ready to use) 4°C buffer ARG82754-006 HRP-Streptavidin 1 vial (100 µl) 4°C concentrate (100X) ARG82754-007 HRP-Streptavidin 12 ml (Ready to use) 4°C diluent buffer ARG82754-008 25X Wash buffer 20 ml 4°C ARG82754-009 TMB substrate 10 ml (Ready to use) 4°C (Protect from light) ARG82754-010 STOP solution 10 ml (Ready to use) 4°C ARG82754-011 Plate sealer 4 strips Room temperature Summary Product Description ARG82754 Human PRELP ELISA Kit is an Enzyme Immunoassay kit for the quantification of Human PRELP in serum, plasma (EDTA, heparin, citrate) and cell culture supernatants. Tested Reactivity Hu Tested Application ELISA Target Name PRELP Conjugation HRP Conjugation Note Substrate: TMB and read at 450 nm. Sensitivity 50 pg/ml Sample Type Serum, plasma (EDTA, heparin, citrate) and cell culture supernatants. Standard Range 93.8 - 6000 pg/ml Sample Volume 100 µl Precision Intra-Assay CV: 5.8% Inter-Assay CV: 6.3% www.arigobio.com 1/2 Alternate Names MST161; SLRR2A; Prolargin; Proline-arginine-rich end leucine-rich repeat protein; MSTP161 Application Instructions Assay Time ~ 5 hours Properties Form 96 well Storage instruction Store the kit at 2-8°C.
    [Show full text]
  • Cell-Deposited Matrix Improves Retinal Pigment Epithelium Survival on Aged Submacular Human Bruch’S Membrane
    Retinal Cell Biology Cell-Deposited Matrix Improves Retinal Pigment Epithelium Survival on Aged Submacular Human Bruch’s Membrane Ilene K. Sugino,1 Vamsi K. Gullapalli,1 Qian Sun,1 Jianqiu Wang,1 Celia F. Nunes,1 Noounanong Cheewatrakoolpong,1 Adam C. Johnson,1 Benjamin C. Degner,1 Jianyuan Hua,1 Tong Liu,2 Wei Chen,2 Hong Li,2 and Marco A. Zarbin1 PURPOSE. To determine whether resurfacing submacular human most, as cell survival is the worst on submacular Bruch’s Bruch’s membrane with a cell-deposited extracellular matrix membrane in these eyes. (Invest Ophthalmol Vis Sci. 2011;52: (ECM) improves retinal pigment epithelial (RPE) survival. 1345–1358) DOI:10.1167/iovs.10-6112 METHODS. Bovine corneal endothelial (BCE) cells were seeded onto the inner collagenous layer of submacular Bruch’s mem- brane explants of human donor eyes to allow ECM deposition. here is no fully effective therapy for the late complications of age-related macular degeneration (AMD), the leading Control explants from fellow eyes were cultured in medium T cause of blindness in the United States. The prevalence of only. The deposited ECM was exposed by removing BCE. Fetal AMD-associated choroidal new vessels (CNVs) and/or geo- RPE cells were then cultured on these explants for 1, 14, or 21 graphic atrophy (GA) in the U.S. population 40 years and older days. The explants were analyzed quantitatively by light micros- is estimated to be 1.47%, with 1.75 million citizens having copy and scanning electron microscopy. Surviving RPE cells from advanced AMD, approximately 100,000 of whom are African explants cultured for 21 days were harvested to compare bestro- American.1 The prevalence of AMD increases dramatically with phin and RPE65 mRNA expression.
    [Show full text]
  • Proteoglycan Form and Function: a Comprehensive Nomenclature of Proteoglycans
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Matrix Biol Manuscript Author . Author manuscript; Manuscript Author available in PMC 2016 May 06. Published in final edited form as: Matrix Biol. 2015 March ; 42: 11–55. doi:10.1016/j.matbio.2015.02.003. Proteoglycan form and function: A comprehensive nomenclature of proteoglycans Renato V. Iozzo1 and Liliana Schaefer2 1Department of Pathology, Anatomy and Cell Biology and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA 2Pharmazentrum Frankfurt/ZAFES, Institut für Allgemeine Pharmakologie und Toxikologie, Klinikum der Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany Abstract We provide a comprehensive classification of the proteoglycan gene families and respective protein cores. This updated nomenclature is based on three criteria: Cellular and subcellular location, overall gene/protein homology, and the utilization of specific protein modules within their respective protein cores. These three signatures were utilized to design four major classes of proteoglycans with distinct forms and functions: the intracellular, cell-surface, pericellular and extracellular proteoglycans. The proposed nomenclature encompasses forty-three distinct proteoglycan-encoding genes and many alternatively-spliced variants. The biological functions of these four proteoglycan families are critically assessed in development, cancer and angiogenesis, and in various acquired and genetic diseases where their expression is aberrant. Keywords Proteoglycan; Glycosaminoglycan; Cancer growth; Angiogenesis; Growth factor modulation Introduction It has been nearly 20 years since the original publication of a comprehensive classification of proteoglycan gene families [1]. For the most part, these classes have been widely accepted. However, a broad and current taxonomy of the various proteoglycan gene families and their products is not available.
    [Show full text]
  • Chondrocyte Secretome: a Source of Novel Insights and Exploratory Biomarkers of Osteoarthritis
    Osteoarthritis and Cartilage xxx (2017) 1e11 Review Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis * C. Sanchez yz , A.-C. Bay-Jensen zx,T.Papzk, M. Dvir-Ginzberg z ¶, H. Quasnichka zyy, R. Barrett-Jolley z #, A. Mobasheri zyyzzxxkk, Y. Henrotin yz y Bone and Cartilage Research Unit, Arthropole^ Liege, University of Liege, CHU Sart-Tilman, Belgium z The D-BOARD European Consortium for Biomarker Discovery x Department of Rheumatology, Biomarkers and Research, Nordic Bioscience, Herlev Hovedgade 207, 2730, Herlev, Denmark k Institute of Experimental Musculoskeletal Medicine, University Hospital Munster, Domagkstrasse 3, D-48149, Munster, Germany ¶ Institute of Dental Sciences, Faculty of Dental Medicine, Hebrew University of Jerusalem, P.O. Box 12272, Jerusalem, 91120, Israel # Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, Faculty of Health & Life Sciences, University of Liverpool, Liverpool, United Kingdom yy Department of Veterinary Pre-Clinical Sciences, School of Veterinary Medicine, University of Surrey, Guildford, GU2 7AL, United Kingdom zz Faculty of Health and Medical Sciences, Duke of Kent Building, University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom xx Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis, Queen's Medical Centre, Nottingham, NG7 2UH, United Kingdom kk Center of Excellence in Genomic Medicine Research (CEGMR), King Fahd Medical Research Center (KFMRC), Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia article info summary Article history: The extracellular matrix (ECM) of articular cartilage is comprised of complex networks of proteins and Received 30 November 2016 glycoproteins, all of which are expressed by its resident cell, the chondrocyte.
    [Show full text]
  • Mapping the Differential Distribution of Proteoglycan Core Proteins in the Adult Human Retina, Choroid, and Sclera
    Anatomy and Pathology Mapping the Differential Distribution of Proteoglycan Core Proteins in the Adult Human Retina, Choroid, and Sclera Tiarnan D. L. Keenan,1,3,4 Simon J. Clark,1,4 Richard D. Unwin,4 Liam A. Ridge,2 Anthony J. Day,*,2 and Paul N. Bishop*,1,3,4 PURPOSE. To examine the presence and distribution of comprehensive analysis of the presence and distribution of proteoglycan (PG) core proteins in the adult human retina, PG core proteins throughout the human retina, choroid, and choroid, and sclera. sclera. This complements our knowledge of glycosaminoglycan chain distribution in the human eye, and has important METHODS. Postmortem human eye tissue was dissected into Bruch’s membrane/choroid complex, isolated Bruch’s mem- implications for understanding the structure and functional brane, or neurosensory retina. PGs were extracted and partially regulation of the eye in health and disease. (Invest Ophthalmol 2012;53:7528–7538) DOI:10.1167/iovs.12-10797 purified by anion exchange chromatography. Trypsinized Vis Sci. peptides were analyzed by tandem mass spectrometry and PG core proteins identified by database search. The distribu- roteoglycans (PGs) are present in mammalian tissues, both tion of PGs was examined by immunofluorescence microscopy Pon cell surfaces and in the extracellular matrix, where they on human macular tissue sections. play crucial roles in development, homeostasis, and disease.1,2 RESULTS. The basement membrane PGs perlecan, agrin, and PGs are composed of a core protein covalently bound to one or collagen-XVIII were identified in the human retina, and were more glycosaminoglycan (GAG) chains, where the core protein present in the internal limiting membrane, blood vessel walls, typically consists of multiple domains with distinct structural and Bruch’s membrane.
    [Show full text]
  • Wild Mice with Different Social Network Sizes Vary in Brain Gene Expression Patricia C
    Lopes and König BMC Genomics (2020) 21:506 https://doi.org/10.1186/s12864-020-06911-5 RESEARCH ARTICLE Open Access Wild mice with different social network sizes vary in brain gene expression Patricia C. Lopes1* and Barbara König2 Abstract Background: Appropriate social interactions influence animal fitness by impacting several processes, such as mating, territory defense, and offspring care. Many studies shedding light on the neurobiological underpinnings of social behavior have focused on nonapeptides (vasopressin, oxytocin, and homologues) and on sexual or parent- offspring interactions. Furthermore, animals have been studied under artificial laboratory conditions, where the consequences of behavioral responses may not be as critical as when expressed under natural environments, therefore obscuring certain physiological responses. We used automated recording of social interactions of wild house mice outside of the breeding season to detect individuals at both tails of a distribution of egocentric network sizes (characterized by number of different partners encountered per day). We then used RNA-seq to perform an unbiased assessment of neural differences in gene expression in the prefrontal cortex, the hippocampus and the hypothalamus between these mice with naturally occurring extreme differences in social network size. Results: We found that the neurogenomic pathways associated with having extreme social network sizes differed between the sexes. In females, hundreds of genes were differentially expressed between animals with small and large social network sizes, whereas in males very few were. In males, X-chromosome inactivation pathways in the prefrontal cortex were the ones that better differentiated animals with small from those with large social network sizes animals. In females, animals with small network size showed up-regulation of dopaminergic production and transport pathways in the hypothalamus.
    [Show full text]
  • Genetic Variation and Functional Analysis of the Cardiomedin Gene
    TECHNISCHE UNIVERSITÄT MÜNCHEN LEHRSTUHL FÜR EXPERIMENTELLE GENETIK Genetic Variation and Functional Analysis of the Cardiomedin Gene Zasie Susanne Schäfer Vollständiger Abdruck der von der Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigten Dissertation. Vorsitzende: Univ.-Prof. A. Schnieke, Ph.D. Prüfer der Dissertation: 1. apl. Prof. Dr. J. Adamski 2. Univ.-Prof. Dr. Dr. H.-R. Fries 3. Univ.-Prof. Dr. Th. Meitinger Die Dissertation wurde am. 31.05.2011 bei der Technischen Universität München eingereicht und durch die Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt am 02.04.2012 angenommen. Table of Contents Table of contents Abbreviations ........................................................................................................................ 7 1. Summary ..........................................................................................................................10 Zusammenfassung ...............................................................................................................11 2. Introduction ......................................................................................................................12 2.1 Genome-wide association studies (GWAS) and post-GWAS functional genomics ......12 2.2 Genetic influences on cardiac repolarization and sudden cardiac death syndrome in GWAS and the chromosome
    [Show full text]
  • Tumor-Antagonizing Fibroblasts Secrete Prolargin As Tumor Suppressor in Hepatocellular Carcinoma
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.04.425182; this version posted March 2, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Tumor-Antagonizing Fibroblasts Secrete Prolargin as Tumor Suppressor in Hepatocellular Carcinoma Barbara Chiavarina1,2,3, Roberto Ronca4, Yukihiro Otaka5,6, Roger Bryan Sutton7, Sara Rezzola4, Takehiko Yokobori6,8, Paola Chiodelli4, Regis Souche1,2,3, Antonio Maraver2,3,9, Gavino Faa10, Tetsunari Oyama11, Stephanie Gofflot12, Akeila Bellahcène13, Olivier Detry14, Philippe Delvenne15, Vincent Castronovo13, Masahiko Nishiyama5,6*, Andrei Turtoi1,2,3,6* 1Tumor Microenvironment and Resistance to Treatment Lab, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Montpellier, France 2Université de Montpellier, Montpellier, France 3Institut régional du Cancer de Montpellier (ICM)-Val d’Aurelle, Montpellier, France 4University of Brescia, Department of Molecular and Translational Medicine, Brescia, Italy 5Department of Molecular Pharmacology and Oncology, Gunma University Graduate School of Medicine, Gunma, Japan 6Gunma University Initiative for Advanced Research (GIAR), Maebashi, Gunma, Japan 7Department of Cell Physiology and Molecular Biophysics, Texas Tech University Health Sciences Center, Lubbock, TX, 79430, USA 8Department of General Surgical Science, Graduate School of Medicine, Gunma University Maebashi, Gunma, Japan 9Oncogenic Pathways in Lung Cancer Lab, Institut
    [Show full text]
  • Download File
    Supplemental Table 3. Genes over- or under-expressed in late passage compared to early passage fibroblasts, independently of +21 (2-way ANOVA, p<.001.) 2-way ANOVA p value; late vs early passage fold difference fold difference independent of late vs early late vs early Affy ID +21 passage C passage +21 Symbol Synonym Genbank Description 41814_at 0.00056 4.12 2.37 FUCA1 FUCA1 M29877 Fucosidase, alpha-L- 1, tissue 36136_at 0.00026 3.87 3.38 PIG11 PIG11 AF010315 Tumor protein p53 inducible protein 11 34842_at 0.00029 3.76 2.69 SNRPN SNRPN U41303 SNRPN upstream reading frame 1120_at 0.00021 3.12 2.16 GSTM3 GSTM3 J05459 Glutathione S-transferase M3 (brain) 35576_f_at 0.00009 3.09 3.11 H2BFC H2BFC AL009179 H2B histone family, member C 41237_at 0.00032 3.03 1.85 HLA-A HLA-A D32129 Major histocompatibility complex, class I, A 32822_at 0.00064 3.01 1.41 ANT1 SLC25A4 J02966 mitochondrial carrier; adenine nucleotide translocator 40120_at 0.00009 2.99 2.40 HAGH1 HAGH X90999 Hydroxyacylglutathione hydrolase 36347_f_at 0.00003 2.81 4.12 HIST1H2BN H2BFD AA873858 Histone 1, H2bn 1243_at 0.00008 2.69 2.74 DDB2 DDB2 U18300 Damage-specific DNA binding protein 2, XP group E gene 37022_at 0.00014 2.69 3.81 PRELP PRELP U41344 leucine-rich repeat protein of articular cartilage; prolargin 39340_at 0.00008 2.63 2.37 HEXA HEXA M16424 beta-hexosaminidase alpha chain 35329_at 0.00002 2.58 2.42 CYB5R1 CYB5R1 AF091084 NAD(P)H:quinone oxidoreductase type 3, polypeptide A2 39369_at 0.00014 2.57 2.11 KIAA0935 KIAA0935 AB023152 Mannosidase, alpha, class 2B, member 2 40454_at 0.00084 2.47 1.65 hFat FAT X87241 FAT tumor suppressor homolog 1 (Drosophila) 41627_at 0.00045 2.38 1.97 SDF2 SDF2 D50645 Stromal cell-derived factor 2 32566_at 0.00044 2.36 1.64 FLJ22678 FLJ22678 AA165701 Chondroitin polymerizing factor 32819_at 0.00001 2.32 2.79 HIRIP1 H2BFT AJ223352 Histone 1, H2bk 31522_f_at 0.00011 2.31 2.82 H2B/g H2BFG Z80779 H.sapiens H2B/g gene.
    [Show full text]